phase iii study finds initial nivolumab-based treatment halts melanoma progression
Published 9 years ago • 99 plays • Length 6:35Download video MP4
Download video MP3
Similar videos
-
6:24
initial nivolumab-based treatment halts melanoma progression
-
2:37
comment: nivolumab-based treatment halts melanoma progression
-
10:05
nivolumab alone superior to ipilimumab alone in advanced melanoma
-
2:57
neoadjuvent ipilimumab plus nivolumab beneficial compared to adjuvent nivolumab in macroscopic, ...
-
5:37
phase iii trial shows pembrolizumab preferable to ipilimumab in advanced melanoma
-
4:07
phase ii trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
24:18
pembrolizumab is better than ipilimumab for advanced melanoma in phase iii trial
-
1:34
fda approves frontline nivolumab for advanced melanoma
-
0:49
scandium 2: ihp with ipilimumab and nivolumab in uveal melanoma metastases
-
1:52
hcrn gu16-260: nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with adv...
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
3:30
dosing regiment in the combination of ipilimumab and nivolumab in stage iii melanoma
-
7:41
nivolumab potentially superior to standard chemo in advanced melanoma
-
4:15
two positive phase iii rcc studies, nivolumab approved for nsclc in europe, and more
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
1:49
sclc hyperprogression with nivolumab
-
5:03
anti-pd-1 drug nivolumab shows high and durable clinical activity in advanced melanoma